CEREVEL THERAPEUTICS HOLDINGS
CERE Insider Trades:
all
Powered by unusualwhales.com
Ticker
Trade Date
Filing Date
Name
Title
Code
Security
Amount
Price
Value
Trans.
10b5-1
Director
10% Owner
Mcap/AUM
2024-08-01
2024-08-05
TREGONING KATHLEEN
Chief Corporate Affairs Office...
D - Sale to Issuer
Restricted Stock Units
-59,171
$0.00
1
$0
2024-08-01
2024-08-05
AKAMINE SCOTT
Chief Legal Officer
D - Sale to Issuer
Restricted Stock Units
-59,171
$0.00
1
$0
2024-08-01
2024-08-05
AKAMINE SCOTT
Chief Legal Officer
D - Sale to Issuer
Stock Option (Right to Buy)
-367K
1
$0
2024-08-01
2024-08-05
ALTSCHULLER SUSAN
Chief Financial Officer
D - Sale to Issuer
Restricted Stock Units
-81,065
$0.00
1
$0
2024-08-01
2024-08-05
ALTSCHULLER SUSAN
Chief Financial Officer
D - Sale to Issuer
Stock Option (Right to Buy)
-124K
1
$0
2024-08-01
2024-08-05
ALTSCHULLER SUSAN
Chief Financial Officer
D - Sale to Issuer
Common Stock
-16,913
1
$0
2024-08-01
2024-08-05
BODENRADER MARK
Senior Vice President, Finance...
D - Sale to Issuer
Restricted Stock Units
-24,852
$0.00
1
$0
2024-08-01
2024-08-05
BODENRADER MARK
Senior Vice President, Finance...
D - Sale to Issuer
Stock Option (Right to Buy)
-278K
1
$0
2024-08-01
2024-08-05
BODENRADER MARK
Senior Vice President, Finance...
D - Sale to Issuer
Common Stock
-17,724
1
$0
2024-08-01
2024-08-05
BURGESS PAUL
Chief Business Development and...
D - Sale to Issuer
Restricted Stock Units
-81,065
$0.00
1
$0
2024-08-01
2024-08-05
BURGESS PAUL
Chief Business Development and...
D - Sale to Issuer
Stock Option (Right to Buy)
-95,931
1
$0
2024-08-01
2024-08-05
BURGESS PAUL
Chief Business Development and...
D - Sale to Issuer
Common Stock
-45,727
1
$0
2024-08-01
2024-08-05
DIPIETRO KENNETH
Chief Human Resources Officer
D - Sale to Issuer
Restricted Stock Units
-63,905
$0.00
1
$0
2024-08-01
2024-08-05
DIPIETRO KENNETH
Chief Human Resources Officer
D - Sale to Issuer
Stock Option (Right to Buy)
-712K
1
$0
2024-08-01
2024-08-05
DIPIETRO KENNETH
Chief Human Resources Officer
D - Sale to Issuer
Common Stock
-25,042
1
$0
2024-08-01
2024-08-05
RENAUD RONALD JR
President & CEO
D - Sale to Issuer
Performance-based Restricted Stock Units
-321K
$0.00
1
$0
2024-08-01
2024-08-05
RENAUD RONALD JR
President & CEO
D - Sale to Issuer
Restricted Stock Units
-284K
$0.00
1
$0
2024-08-01
2024-08-05
RENAUD RONALD JR
President & CEO
D - Sale to Issuer
Stock Option (Right to Buy)
-216K
1
$0
2024-08-01
2024-08-05
RENGER JOHN
Chief Scientific Officer
D - Sale to Issuer
Restricted Stock Units
-103K
$0.00
2
$0
2024-08-01
2024-08-05
RENGER JOHN
Chief Scientific Officer
D - Sale to Issuer
Stock Option (Right to Buy)
-778K
1
$0
2024-08-01
2024-08-05
SANCHEZ RAMIRO
Chief Medical Officer
D - Sale to Issuer
Restricted Stock Units
-87,573
$0.00
1
$0
2024-08-01
2024-08-05
SANCHEZ RAMIRO
Chief Medical Officer
D - Sale to Issuer
Stock Option (Right to Buy)
-1.39M
1
$0
2024-08-01
2024-08-05
TREGONING KATHLEEN
Chief Corporate Affairs Office...
D - Sale to Issuer
Stock Option (Right to Buy)
-614K
1
$0
2024-08-01
2024-08-05
TREGONING KATHLEEN
Chief Corporate Affairs Office...
D - Sale to Issuer
Common Stock
-10,666
1
$0
2024-02-07
2024-02-08
RENGER JOHN
Chief Scientific Officer
S - Sale
Common Stock
-2,161
$42.00
-90,762
1
$0
2024-02-06
2024-02-08
RENGER JOHN
Chief Scientific Officer
M - Exercise
Restricted Stock Units
-5,020
$0.00
1
$0
2024-01-19
2024-01-23
BODENRADER MARK
Title: Senior Vice President, ...
A - Grant
Restricted Stock Units
24,852
$0.00
1
$0
2024-01-19
2024-01-23
AKAMINE SCOTT
Chief Legal Officer
A - Grant
Restricted Stock Units
59,171
$0.00
1
$0
2024-01-19
2024-01-23
ALTSCHULLER SUSAN
Chief Financial Officer
A - Grant
Restricted Stock Units
81,065
$0.00
1
$0
2024-01-19
2024-01-23
BURGESS PAUL
Title: Chief Business Developm...
A - Grant
Restricted Stock Units
81,065
$0.00
1
$0
2024-01-19
2024-01-23
DIPIETRO KENNETH
Chief Human Resources Officer
A - Grant
Restricted Stock Units
63,905
$0.00
1
$0
2024-01-19
2024-01-23
RENGER JOHN
Chief Scientific Officer
A - Grant
Restricted Stock Units
87,573
$0.00
1
$0
2024-01-19
2024-01-23
SANCHEZ RAMIRO
Chief Medical Officer
A - Grant
Restricted Stock Units
87,573
$0.00
1
$0
2024-01-19
2024-01-23
TREGONING KATHLEEN
Title: Chief Corporate Affairs...
A - Grant
Restricted Stock Units
59,171
$0.00
1
$0
2023-12-26
2023-12-28
SANCHEZ RAMIRO
Chief Medical Officer
M - Exercise
Stock Option (Right to Buy)
-10,000
$0.00
1
$0
2023-12-26
2023-12-28
SANCHEZ RAMIRO
Chief Medical Officer
M - Exercise
Common Stock
10,000
$4.00
40,000
1
$0
2023-12-26
2023-12-28
TREGONING KATHLEEN
Title: Chief Corporate Affairs...
M - Exercise
Stock Option (Right to Buy)
-3,150
$0.00
1
$0
2023-12-26
2023-12-28
TREGONING KATHLEEN
Title: Chief Corporate Affairs...
M - Exercise
Common Stock
3,150
$10.00
31,500
1
$0
2023-12-26
2023-12-28
SANCHEZ RAMIRO
Chief Medical Officer
S - Sale
Common Stock
-10,000
$42.00
-420K
1
$0
2023-12-22
2023-12-27
DIPIETRO KENNETH
Chief Human Resources Officer
M - Exercise
Common Stock
8,000
$4.00
32,000
1
$0
2023-12-22
2023-12-27
DIPIETRO KENNETH
Chief Human Resources Officer
M - Exercise
Stock Option (Right to Buy)
-8,000
$0.00
1
$0
2023-12-22
2023-12-27
DIPIETRO KENNETH
Chief Human Resources Officer
S - Sale
Common Stock
-8,000
$41.00
-328K
1
$0
2023-12-20
2023-12-21
TREGONING KATHLEEN
Title: Chief Corporate Affairs...
S - Sale
Common Stock
-6,288
$41.00
-258K
1
$0
2023-12-20
2023-12-21
ALTSCHULLER SUSAN
Chief Financial Officer
S - Sale
Common Stock
-13,808
$41.00
-566K
1
$0
2023-12-20
2023-12-21
BODENRADER MARK
Title: Senior Vice President, ...
S - Sale
Common Stock
-7,889
$41.00
-323K
1
$0
2023-12-20
2023-12-21
DIPIETRO KENNETH
Chief Human Resources Officer
S - Sale
Common Stock
-6,256
$41.00
-256K
1
$0
2023-12-20
2023-12-21
SANCHEZ RAMIRO
Chief Medical Officer
S - Sale
Common Stock
-10,152
$41.00
-416K
1
$0
2023-12-19
2023-12-21
BURGESS PAUL
Title: Chief Business Developm...
M - Exercise
Restricted Stock Units
-23,847
$0.00
1
$0
2023-12-19
2023-12-21
BURGESS PAUL
Title: Chief Business Developm...
M - Exercise
Common Stock
23,847
1
$0
2023-12-19
2023-12-21
DIPIETRO KENNETH
Chief Human Resources Officer
M - Exercise
Restricted Stock Units
-13,913
$0.00
1
$0
2023-12-19
2023-12-21
DIPIETRO KENNETH
Chief Human Resources Officer
M - Exercise
Common Stock
13,913
1
$0
2023-12-19
2023-12-21
RENAUD RONALD JR
President & CEO
M - Exercise
Restricted Stock Units
-160K
$0.00
1
$0
2023-12-19
2023-12-21
SANCHEZ RAMIRO
Chief Medical Officer
M - Exercise
Restricted Stock Units
-24,825
$0.00
1
$0
2023-12-19
2023-12-21
TREGONING KATHLEEN
Title: Chief Corporate Affairs...
M - Exercise
Restricted Stock Units
-13,804
$0.00
1
$0
2023-12-19
2023-12-21
TREGONING KATHLEEN
Title: Chief Corporate Affairs...
M - Exercise
Common Stock
13,804
1
$0
2023-12-19
2023-12-21
AKAMINE SCOTT
Chief Legal Officer
M - Exercise
Restricted Stock Units
-13,796
$0.00
1
$0
2023-12-19
2023-12-21
ALTSCHULLER SUSAN
Chief Financial Officer
M - Exercise
Restricted Stock Units
-30,721
$0.00
1
$0
2023-12-19
2023-12-21
BODENRADER MARK
Title: Senior Vice President, ...
M - Exercise
Restricted Stock Units
-19,284
$0.00
2
$0
2023-12-19
2023-12-21
BODENRADER MARK
Title: Senior Vice President, ...
M - Exercise
Common Stock
19,284
2
$0
2023-12-15
2023-12-19
SANCHEZ RAMIRO
Chief Medical Officer
M - Exercise
Stock Option (Right to Buy)
-7,500
$0.00
1
$0
2023-12-15
2023-12-19
SANCHEZ RAMIRO
Chief Medical Officer
M - Exercise
Common Stock
7,500
$10.00
75,000
1
$0
2023-12-07
2023-12-11
SANCHEZ RAMIRO
Chief Medical Officer
M - Exercise
Common Stock
10,000
$4.00
40,000
1
$0
2023-12-07
2023-12-11
SANCHEZ RAMIRO
Chief Medical Officer
S - Sale
Common Stock
-10,000
$41.00
-410K
1
$0
2023-12-07
2023-12-11
SANCHEZ RAMIRO
Chief Medical Officer
M - Exercise
Stock Option (Right to Buy)
-10,000
$0.00
1
$0
2023-12-07
2023-12-07
AKAMINE SCOTT
Chief Legal Officer
M - Exercise
Stock Option (Right to Buy)
-10,000
$0.00
1
$0
2023-12-05
2023-12-07
AKAMINE SCOTT
Chief Legal Officer
M - Exercise
Stock Option (Right to Buy)
-7,500
$0.00
1
$0
2023-12-05
2023-12-07
AKAMINE SCOTT
Chief Legal Officer
M - Exercise
Common Stock
7,500
$13.00
97,500
1
$0
2023-08-04
2023-08-07
BURGESS PAUL
Chief Business Development and...
P - Purchase
Common Stock
21,880
$23.00
503K
1
$0
2023-07-03
2023-07-06
BURGESS PAUL
Title: Chief Business Developm...
A - Grant
Restricted Stock Units
23,847
$0.00
1
$0
2023-07-03
2023-07-06
BURGESS PAUL
Title: Chief Business Developm...
A - Grant
Stock Option (Right to Buy)
95,931
$0.00
1
$0
2023-06-12
2023-06-14
RENAUD RONALD JR
President & CEO
A - Grant
Performance-based Restricted Stock Units
160K
$0.00
1
$0
2023-06-12
2023-06-14
RENAUD RONALD JR
President & CEO
A - Grant
Stock Option (Right to Buy)
216K
$0.00
1
$0
2023-06-02
2023-06-05
BODENRADER MARK
Title: Senior Vice President, ...
S - Sale
Common Stock
-1,895
$33.00
-62,535
1
$0
2023-06-01
2023-06-05
BODENRADER MARK
Title: Senior Vice President, ...
M - Exercise
Common Stock
4,733
1
$0
2023-06-01
2023-06-05
ALTSCHULLER SUSAN
Chief Financial Officer
A - Grant
Restricted Stock Units
30,721
$0.00
1
$0
2023-06-01
2023-06-05
ALTSCHULLER SUSAN
Chief Financial Officer
A - Grant
Stock Option (Right to Buy)
124K
$0.00
1
$0
2023-06-01
2023-06-05
BODENRADER MARK
Title: Senior Vice President, ...
M - Exercise
Restricted Stock Units
-4,733
$0.00
1
$0
2023-06-01
2023-06-05
COLES ANTHONY
CEO and Chairperson
M - Exercise
Stock Option (Right to Buy)
-50,000
$0.00
1
$0
2023-05-04
2023-05-08
COLES ANTHONY
CEO and Chairperson
M - Exercise
Stock Option (Right to Buy)
-50,000
$0.00
1
$0
2023-04-11
2023-04-13
COLES ANTHONY
CEO and Chairperson
M - Exercise
Stock Option (Right to Buy)
-50,000
$0.00
1
$0
2023-03-03
2023-03-06
COLES ANTHONY
CEO and Chairperson
M - Exercise
Stock Option (Right to Buy)
-3,000
$0.00
1
$0
2023-03-02
2023-03-06
COLES ANTHONY
CEO and Chairperson
M - Exercise
Stock Option (Right to Buy)
-47,000
$0.00
1
$0
2023-02-07
2023-02-08
COLES ANTHONY
CEO and Chairperson
M - Exercise
Stock Option (Right to Buy)
-50,000
$0.00
1
$0
2023-02-06
2023-02-08
AKAMINE SCOTT
Chief Legal Officer
A - Grant
Restricted Stock Units
13,796
$0.00
1
$0
2023-02-06
2023-02-08
AKAMINE SCOTT
Chief Legal Officer
A - Grant
Stock Option (Right to Buy)
54,292
$0.00
1
$0
2023-02-06
2023-02-08
BODENRADER MARK
Exhibit 24 - Power of Attorney...
A - Grant
Restricted Stock Units
5,085
$0.00
1
$0
2023-02-06
2023-02-08
BODENRADER MARK
Exhibit 24 - Power of Attorney...
A - Grant
Stock Option (Right to Buy)
20,012
$0.00
1
$0
2023-02-06
2023-02-08
COLES ANTHONY
CEO and Chairperson
A - Grant
Restricted Stock Units
61,762
$0.00
1
$0
2023-02-06
2023-02-08
COLES ANTHONY
CEO and Chairperson
A - Grant
Stock Option (Right to Buy)
243K
$0.00
1
$0
2023-02-06
2023-02-08
DIPIETRO KENNETH
Chief Human Resources Officer
A - Grant
Restricted Stock Units
13,913
$0.00
1
$0
2023-02-06
2023-02-08
DIPIETRO KENNETH
Chief Human Resources Officer
A - Grant
Stock Option (Right to Buy)
54,749
$0.00
1
$0
2023-02-06
2023-02-08
RENGER JOHN
Chief Scientific Officer
A - Grant
Restricted Stock Units
20,081
$0.00
1
$0
2023-02-06
2023-02-08
RENGER JOHN
Chief Scientific Officer
A - Grant
Stock Option (Right to Buy)
79,022
$0.00
1
$0
2023-02-06
2023-02-08
SANCHEZ RAMIRO
Chief Medical Officer
A - Grant
Restricted Stock Units
24,825
$0.00
1
$0
2023-02-06
2023-02-08
SANCHEZ RAMIRO
Chief Medical Officer
A - Grant
Stock Option (Right to Buy)
97,691
$0.00
1
$0
2023-02-06
2023-02-08
TREGONING KATHLEEN
Exhibit 24 - Power of Attorney...
A - Grant
Restricted Stock Units
13,804
$0.00
1
$0
2023-02-06
2023-02-08
TREGONING KATHLEEN
Exhibit 24 - Power of Attorney...
A - Grant
Stock Option (Right to Buy)
54,320
$0.00
1
$0
2023-01-05
2023-01-06
COLES ANTHONY
CEO and Chairperson
M - Exercise
Stock Option (Right to Buy)
-50,000
$0.00
1
$0
2022-12-09
2022-12-13
COLES ANTHONY
CEO and Chairperson
M - Exercise
Stock Option (Right to Buy)
-50,000
$0.00
1
$0
2022-11-01
2022-11-03
RENGER JOHN
Chief Scientific Officer
M - Exercise
Stock Option (Right to Buy)
-25,000
$0.00
2
$0
2022-11-01
2022-11-03
RENGER JOHN
Chief Scientific Officer
S - Sale
Common Stock
-25,000
$30.00
-750K
1
$0
2022-11-01
2022-11-03
RENGER JOHN
Chief Scientific Officer
M - Exercise
Common Stock
25,000
$8.00
200K
2
$0
2022-10-04
2022-10-06
RENGER JOHN
Chief Scientific Officer
M - Exercise
Common Stock
25,000
$8.00
200K
2
$0
2022-10-04
2022-10-06
RENGER JOHN
Chief Scientific Officer
S - Sale
Common Stock
-25,000
$30.00
-750K
1
$0
2022-10-04
2022-10-06
RENGER JOHN
Chief Scientific Officer
M - Exercise
Stock Option (Right to Buy)
-25,000
$0.00
2
$0
2022-09-08
2022-09-12
CEESAY ABRAHAM
President
M - Exercise
Stock Option (Right to Buy)
-19,210
$0.00
1
$0
2022-08-22
2022-08-24
CEESAY ABRAHAM
President
M - Exercise
Stock Option (Right to Buy)
-9,605
$0.00
1
$0
2022-08-16
2022-08-18
PERCEPTIVE ADVISORS LLC
P - Purchase
2.50% Convertible Senior Notes Due 2027
2.16M
$100,000,000.00
215.61T
1
$0
2022-08-15
2022-08-17
CEESAY ABRAHAM
President
M - Exercise
Stock Option (Right to Buy)
-9,606
$0.00
1
$0
2022-08-10
2022-08-12
RENGER JOHN
Chief Scientific Officer
S - Sale
Common Stock
-55,000
$41.00
-2.25M
2
$0
2022-08-10
2022-08-12
RENGER JOHN
Chief Scientific Officer
M - Exercise
Stock Option (Right to Buy)
-55,000
$0.00
2
$0
2022-08-10
2022-08-12
RENGER JOHN
Chief Scientific Officer
M - Exercise
Common Stock
55,000
$7.00
385K
2
$0
2022-08-08
2022-08-09
RENGER JOHN
Chief Scientific Officer
M - Exercise
Common Stock
10,000
$4.00
40,000
1
$0
2022-08-08
2022-08-09
RENGER JOHN
Chief Scientific Officer
M - Exercise
Stock Option (Right to Buy)
-10,000
$0.00
1
$0
2022-08-08
2022-08-09
AKAMINE SCOTT
Chief Legal Officer
M - Exercise
Stock Option (Right to Buy)
-10,000
$0.00
1
$0
2022-08-08
2022-08-09
CEESAY ABRAHAM
President
M - Exercise
Stock Option (Right to Buy)
-19,211
$0.00
1
$0
2022-08-08
2022-08-09
RENGER JOHN
Chief Scientific Officer
S - Sale
Common Stock
-10,000
$38.00
-380K
1
$0
2022-08-05
2022-08-09
RENGER JOHN
Chief Scientific Officer
S - Sale
Common Stock
-20,000
$33.00
-660K
1
$0
2022-08-05
2022-08-09
CEESAY ABRAHAM
President
M - Exercise
Stock Option (Right to Buy)
-38,424
$0.00
1
$0
2022-08-05
2022-08-09
RENGER JOHN
Chief Scientific Officer
M - Exercise
Stock Option (Right to Buy)
-20,000
$0.00
1
$0
2022-08-05
2022-08-09
RENGER JOHN
Chief Scientific Officer
M - Exercise
Common Stock
20,000
$4.00
80,000
1
$0
2022-07-20
2022-07-22
RENGER JOHN
Chief Scientific Officer
M - Exercise
Common Stock
25,000
$4.00
100K
1
$0
2022-07-20
2022-07-22
RENGER JOHN
Chief Scientific Officer
S - Sale
Common Stock
-25,000
$30.00
-750K
1
$0
2022-07-20
2022-07-22
RENGER JOHN
Chief Scientific Officer
M - Exercise
Stock Option (Right to Buy)
-25,000
$0.00
1
$0
2022-07-06
2022-07-07
RENGER JOHN
Chief Scientific Officer
S - Sale
Common Stock
-1,105
$33.00
-36,465
1
$0
2022-07-06
2022-07-07
RENGER JOHN
Chief Scientific Officer
M - Exercise
Stock Option (Right to Buy)
-1,105
$0.00
1
$0
2022-07-06
2022-07-07
RENGER JOHN
Chief Scientific Officer
M - Exercise
Common Stock
1,105
$4.00
4,420
1
$0
2022-07-05
2022-07-07
RENGER JOHN
Chief Scientific Officer
S - Sale
Common Stock
-25,000
$30.00
-750K
1
$0
2022-07-05
2022-07-07
RENGER JOHN
Chief Scientific Officer
M - Exercise
Stock Option (Right to Buy)
-25,000
$0.00
1
$0
2022-07-05
2022-07-07
RENGER JOHN
Chief Scientific Officer
M - Exercise
Common Stock
25,000
$4.00
100K
1
$0
2022-06-01
2022-06-03
BODENRADER MARK
Title: Interim Chief Financial...
A - Grant
Restricted Stock Units
18,932
$0.00
1
$0
2022-04-13
2022-04-15
RENGER JOHN
Chief Scientific Officer
M - Exercise
Stock Option (Right to Buy)
-45,000
$0.00
1
$0
2022-04-13
2022-04-15
RENGER JOHN
Chief Scientific Officer
S - Sale
Common Stock
-45,000
$35.00
-1.57M
1
$0
2022-04-13
2022-04-15
RENGER JOHN
Chief Scientific Officer
M - Exercise
Common Stock
45,000
$4.00
180K
1
$0
2022-03-29
2022-03-31
RENGER JOHN
Chief Scientific Officer
M - Exercise
Common Stock
10,000
$4.00
40,000
1
$0
2022-03-29
2022-03-31
RENGER JOHN
Chief Scientific Officer
M - Exercise
Stock Option (Right to Buy)
-10,000
$0.00
1
$0
2022-03-29
2022-03-31
RENGER JOHN
Chief Scientific Officer
S - Sale
Common Stock
-10,000
$35.00
-350K
1
$0
2022-03-18
2022-03-18
RENGER JOHN
Chief Scientific Officer
M - Exercise
Stock Option (Right to Buy)
-20,000
$0.00
1
$0
2022-03-18
2022-03-18
RENGER JOHN
Chief Scientific Officer
M - Exercise
Common Stock
20,000
$4.00
80,000
1
$0
2022-03-18
2022-03-18
RENGER JOHN
Chief Scientific Officer
S - Sale
Common Stock
-20,000
$33.00
-660K
1
$0
2022-03-16
2022-03-18
RENGER JOHN
Chief Scientific Officer
S - Sale
Common Stock
-25,000
$30.00
-750K
1
$0
2022-03-16
2022-03-18
RENGER JOHN
Chief Scientific Officer
M - Exercise
Stock Option (Right to Buy)
-25,000
$0.00
1
$0
2022-03-16
2022-03-18
RENGER JOHN
Chief Scientific Officer
M - Exercise
Common Stock
25,000
$4.00
100K
1
$0
2022-03-09
2022-03-11
RENGER JOHN
Chief Scientific Officer
S - Sale
Common Stock
-30,000
$33.00
-990K
2
$0
2022-03-09
2022-03-11
RENGER JOHN
Chief Scientific Officer
M - Exercise
Stock Option (Right to Buy)
-30,000
$0.00
1
$0
2022-03-09
2022-03-11
RENGER JOHN
Chief Scientific Officer
M - Exercise
Common Stock
30,000
$4.00
120K
1
$0
2022-03-02
2022-03-04
RENGER JOHN
Chief Scientific Officer
S - Sale
Common Stock
-25,000
$30.00
-750K
1
$0
2022-03-02
2022-03-04
RENGER JOHN
Chief Scientific Officer
M - Exercise
Stock Option (Right to Buy)
-25,000
$0.00
1
$0
2022-03-02
2022-03-04
RENGER JOHN
Chief Scientific Officer
M - Exercise
Common Stock
25,000
$4.00
100K
1
$0
2022-02-09
2022-02-11
DIPIETRO KENNETH
Chief Human Resources Officer
A - Grant
Stock Option (Right to Buy)
75,985
$0.00
1
$0
2022-02-09
2022-02-11
RENGER JOHN
Chief Scientific Officer
M - Exercise
Common Stock
25,000
$4.00
100K
1
$0
2022-02-09
2022-02-11
RENGER JOHN
Chief Scientific Officer
S - Sale
Common Stock
-25,000
$30.00
-750K
1
$0
2022-02-09
2022-02-11
AKAMINE SCOTT
Chief Legal Officer
A - Grant
Stock Option (Right to Buy)
58,572
$0.00
1
$0
2022-02-09
2022-02-11
BODENRADER MARK
Title: Interim Chief Financia...
A - Grant
Stock Option (Right to Buy)
24,800
$0.00
1
$0
2022-02-09
2022-02-11
COLES ANTHONY
CEO and Chairperson
A - Grant
Stock Option (Right to Buy)
426K
$0.00
1
$0
2022-02-09
2022-02-11
RENGER JOHN
Chief Scientific Officer
A - Grant
Stock Option (Right to Buy)
169K
$0.00
1
$0
2022-02-09
2022-02-11
SANCHEZ RAMIRO
Chief Medical Officer
A - Grant
Stock Option (Right to Buy)
169K
$0.00
1
$0
2022-02-09
2022-02-11
TREGONING KATHLEEN
Chief Corporate Affairs Office...
A - Grant
Stock Option (Right to Buy)
63,321
$0.00
1
$0
2022-02-09
2022-02-11
RENGER JOHN
Chief Scientific Officer
M - Exercise
Stock Option (Right to Buy)
-25,000
$0.00
1
$0
2021-12-27
2021-12-28
RENGER JOHN
Chief Scientific Officer
M - Exercise
Stock Option (Right to Buy)
-4,127
$0.00
1
$0
2021-12-27
2021-12-28
RENGER JOHN
Chief Scientific Officer
M - Exercise
Common Stock
4,127
$4.00
16,508
1
$0
2021-12-23
2021-12-28
RENGER JOHN
Chief Scientific Officer
M - Exercise
Stock Option (Right to Buy)
-5,873
$0.00
1
$0
2021-12-23
2021-12-28
RENGER JOHN
Chief Scientific Officer
M - Exercise
Common Stock
5,873
$4.00
23,492
1
$0
2021-12-21
2021-12-23
RENGER JOHN
Chief Scientific Officer
M - Exercise
Stock Option (Right to Buy)
-7,300
$0.00
1
$0
2021-12-21
2021-12-23
RENGER JOHN
Chief Scientific Officer
M - Exercise
Common Stock
7,300
$4.00
29,200
1
$0
2021-12-17
2021-12-17
RENGER JOHN
Chief Scientific Officer
M - Exercise
Common Stock
7,122
$4.00
28,488
1
$0
2021-12-16
2021-12-17
RENGER JOHN
Chief Scientific Officer
M - Exercise
Stock Option (Right to Buy)
-5,578
$0.00
1
$0
2021-12-16
2021-12-17
RENGER JOHN
Chief Scientific Officer
M - Exercise
Common Stock
5,578
$4.00
22,312
1
$0
2021-12-15
2021-12-17
RENGER JOHN
Chief Scientific Officer
M - Exercise
Common Stock
25,000
$4.00
100K
1
$0
2021-12-15
2021-12-17
RENGER JOHN
Chief Scientific Officer
M - Exercise
Stock Option (Right to Buy)
-25,000
$0.00
1
$0
2021-12-15
2021-12-17
RENGER JOHN
Chief Scientific Officer
S - Sale
Common Stock
-25,000
$30.00
-750K
1
$0
2017-12-17
2021-12-17
RENGER JOHN
Chief Scientific Officer
M - Exercise
Stock Option (Right to Buy)
-7,122
$0.00
1
$0
2021-11-10
2021-11-15
RENGER JOHN
Chief Scientific Officer
S - Sale
Common Stock
-55,000
$40.00
-2.20M
5
$0
2021-11-10
2021-11-15
RENGER JOHN
Chief Scientific Officer
M - Exercise
Stock Option (Right to Buy)
-55,000
$0.00
1
$0
2021-11-10
2021-11-15
RENGER JOHN
Chief Scientific Officer
M - Exercise
Common Stock
55,000
$4.00
220K
1
$0
2021-06-01
2021-06-03
AKAMINE SCOTT
Chief Legal Officer
A - Grant
Stock Option (Right to Buy)
282K
$0.00
1
$0
2021-02-03
2021-02-05
BODENRADER MARK
Vice President, Finance and Ch...
A - Grant
Stock Option (Right to Buy)
90,000
$0.00
1
$0
2021-02-03
2021-02-05
COLES ANTHONY
President and CEO
A - Grant
Stock Option (Right to Buy)
733K
$0.00
1
$0
2021-02-03
2021-02-05
DIPIETRO KENNETH
Chief Human Resources Officer
A - Grant
Stock Option (Right to Buy)
175K
$0.00
1
$0
2021-02-03
2021-02-05
RENGER JOHN
Chief Scientific Officer
A - Grant
Stock Option (Right to Buy)
248K
$0.00
1
$0
2021-02-03
2021-02-05
SANCHEZ RAMIRO
Chief Medical Officer
A - Grant
Stock Option (Right to Buy)
279K
$0.00
1
$0
2021-02-03
2021-02-05
TREGONING KATHLEEN
Chief Corporate Affairs Office...
A - Grant
Stock Option (Right to Buy)
77,399
$0.00
1
$0
2021-02-03
2021-02-05
YI KATHY
Chief Financial Officer
A - Grant
Stock Option (Right to Buy)
217K
$0.00
1
$0
2021-01-26
2021-01-28
MISHAN ORLY
Chief Business Officer
M - Exercise
Stock Option (Right to Buy)
-38,450
$0.00
1
$0
2020-12-04
2020-12-08
TREGONING KATHLEEN
Chief Corporate Affairs Office...
A - Grant
Stock Option (Right to Buy)
78,229
$0.00
1
$0
2020-10-28
2020-10-30
BODENRADER MARK
Vice President, Finance and Ch...
A - Grant
Stock Option (Right to Buy)
65,445
$0.00
1
$0
2020-10-28
2020-10-30
COLES ANTHONY
President and CEO
A - Grant
Stock Option (Right to Buy)
196K
$0.00
1
$0
2020-10-28
2020-10-30
RENGER JOHN
Chief Scientific Officer
A - Grant
Stock Option (Right to Buy)
118K
$0.00
1
$0
2020-10-28
2020-10-30
SANCHEZ RAMIRO
Chief Medical Officer
A - Grant
Stock Option (Right to Buy)
131K
$0.00
1
$0
2020-10-28
2020-10-30
YI KATHY
Chief Financial Officer
A - Grant
Stock Option (Right to Buy)
78,534
$0.00
1
$0